Ergoteles’s Applied Molecular Transport Inc. Common Stock AMTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-25,372
Closed -$10.7K 1918
2022
Q4
$10.7K Sell
25,372
-78,175
-75% -$78.7K ﹤0.01% 1368
2022
Q3
$101K Sell
103,547
-7,942
-7% -$14K ﹤0.01% 1380
2022
Q2
$324K Buy
111,489
+94,085
+541% +$395K 0.01% 1072
2022
Q1
$131K Buy
17,404
+6,031
+53% +$50K 0.01% 1078
2021
Q4
$159K Buy
+11,373
New +$224K 0.01% 1083

Other funds holding AMTI

Ergoteles's AMTI Position: Q1 2023 in Review

Ergoteles sold out of Applied Molecular Transport Inc. Common Stock (AMTI) in Q1 2023, closing a stake of 25,372 shares — an estimated $10.7K sold.

Ergoteles first reported a position in AMTI in Q4 2021 and held it in 5 quarters. The position peaked at $324K in Q2 2022. 35 funds tracked by Wall St. Rank hold AMTI as of Q1 2023.

  • Ergoteles reported no remaining Applied Molecular Transport Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Ergoteles sold 25,372 Applied Molecular Transport Inc. Common Stock shares in Q1 2023, an estimated $10.7K.
  • Ergoteles first reported a position in Applied Molecular Transport Inc. Common Stock in Q4 2021 and held it in 5 quarters.
  • Ergoteles's Applied Molecular Transport Inc. Common Stock position peaked at $324K in Q2 2022.
  • 35 funds tracked by Wall St. Rank held Applied Molecular Transport Inc. Common Stock as of Q1 2023.

Based on Ergoteles's 13F filing for Q1 2023, filed 10 May 2023.